Article Text
PDF
Statistics from Altmetric.com
OpenUrlCrossRefPubMedWeb of Science
Q Does olanzapine prevent relapse of bipolar I disorder in people who have responded to acute treatment with olanzapine for a manic or mixed episode?
METHODS
Design:
Multicentre randomised controlled trial.
Allocation:
Not clear.
Blinding:
Double blind.
Follow up period:
48 weeks.
Setting:
44 sites in the USA and 5 sites in Romania; time period not stated.
Patients:
361 people, aged 18 or over, who achieved symptomatic remission from a DSM-IV bipolar I manic or mixed episode (Young Mania Rating scale (YMRS) score ⩽12 and 21 item Hamilton Depression Rating Scale (HAM-D) score ⩽8 for 2 consecutive weeks) following 6–12 weeks of acute treatment with olanzapine. …
Footnotes
For correspondence: Dr M Tohen, Lilly Research Laboratories, Indianapolis, IN 46285, USA; m.tohen{at}lilly.com
Source of funding: Lilly Research Laboratories, USA.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.